Friday, 16 October 2026European Markets

NEURONES And ITERA Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - neurones (nro.pa) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
neurones (nro.pa) €37.60 2.97% 14.2%
itera (itera.ol) kr13.65 2.24% 99.64%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. neurones (nro.pa)

2.97% forward dividend yield and 14.2% return on equity

neurones s.a., an information technology (it) services company, provides infrastructure, application, and consulting services in france and internationally. its infrastructure services include infrastructure management, manages public and private cloud services, it operations, user support, devops, cybersecurity, it service management, information system governance, and automation. the company also provides application services in the areas of sap, digital, web, mobility, ux/ui, enterprise content and document management, business process management, robotic process automation, dematerialization, it consulting for finance, big data, and devops, it training and change management, and innovation connected devices (iot). in addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, devops, ci/cd, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, ux/ui, and digital marketing, as well as internal process digitization, ecm/bpm, rpa, dematerialization, ai, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. the company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. neurones s.a. was founded in 1984 and is based in nanterre, france.

earnings per share

as for profitability, neurones has a trailing twelve months eps of €1.8.

pe ratio

neurones has a trailing twelve months price to earnings ratio of 20.89. meaning, the purchaser of the share is investing €20.89 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.2%.

volatility

neurones's last week, last month's, and last quarter's current intraday variation average was a positive 0.24%, a negative 0.01%, and a positive 0.96%.

neurones's highest amplitude of average volatility was 1.04% (last week), 0.71% (last month), and 0.96% (last quarter).

more news about neurones.

2. itera (itera.ol)

2.24% forward dividend yield and 99.64% return on equity

itera asa, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in norway, denmark, and slovakia. it offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. the company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. itera asa was founded in 1989 and is based in oslo, norway.

earnings per share

as for profitability, itera has a trailing twelve months eps of kr0.79.

pe ratio

itera has a trailing twelve months price to earnings ratio of 17.28. meaning, the purchaser of the share is investing kr17.28 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 99.64%.

volume

today's last reported volume for itera is 16921 which is 14.91% below its average volume of 19888.

revenue growth

year-on-year quarterly revenue growth grew by 30.8%, now sitting on 790.13m for the twelve trailing months.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on may 25, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 2.24%.

more news about itera.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com